Joanne M. Foody - 08 Aug 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Medical Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
08 Aug 2023
Net transactions value
+$144,666
Form type
4
Filing time
09 Aug 2023, 16:30:21 UTC
Previous filing
20 Apr 2023
Next filing
15 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy Award $72,333 +44,650 $1.62 44,650 08 Aug 2023 Stock Option (right to buy) 44,650 $1.62 Direct F1
transaction ESPR Stock Option (right to buy) Award $72,333 +44,650 $1.62 44,650 08 Aug 2023 Stock Option (right to buy 44,650 $1.62 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on November 15, 2023, subject to continued service.
F2 Such award shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.